Compare · ACN vs PHR
ACN vs PHR
Side-by-side comparison of Accenture plc (ACN) and Phreesia Inc. (PHR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ACN and PHR operate in Real Estate (Real Estate), so they compete in similar markets.
- ACN is the larger of the two at $124.78B, about 175.2x PHR ($712.1M).
- Over the past year, ACN is down 26.8% and PHR is down 62.7% - ACN leads by 35.9 points.
- ACN has been more active in the news (28 items in the past 4 weeks vs 5 for PHR).
- Both have 25 recent analyst ratings on file.
- Company
- Accenture plc
- Phreesia Inc.
- Price
- $187.07+0.24%
- $11.51-1.71%
- Market cap
- $124.78B
- $712.1M
- 1M return
- +21.37%
- +8.18%
- 1Y return
- -26.80%
- -62.68%
- Industry
- Real Estate
- Real Estate
- Exchange
- NYSE
- NYSE
- IPO
- 2001
- 2019
- News (4w)
- 28
- 5
- Recent ratings
- 25
- 25
Accenture plc
Accenture plc, a professional services company, provides strategy and consulting, interactive, and technology and operations services worldwide. The company also provides outsourcing services. It serves communications, media, high tech, software, and platform companies; banking, capital market, and insurance industries; and consumer goods, retail, travel services, industrial, and life science industries, as well as clients in health, public service, chemicals and natural resources, energy, and utility sectors. Accenture plc has alliance relationships with Adobe, Alibaba, Amazon Web Services, Blue Yonder, Cisco, Dell, Google, HPE, IBM RedHat, Microsoft, Oracle, Pegasystems, Salesforce, SAP, ServiceNow, VMWare, Workday, Massachusetts Institute of Technology, Institut Polytechnique de Paris, CNH Industrial, and Reactive Technologies. It has an agreement with Duke Energy Corporation for the development of a technology platform designed to measure actual baseline methane emissions from natural gas distribution systems. The company was incorporated in 2009 and is based in Dublin, Ireland.
Phreesia Inc.
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; appointments solution for online appointments, reminders, and referral tracking; and patient activation solution that enables providers to communicate with their patients through surveys, announcements, messaging, and health campaigns. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and PRO data for approximately 25 specialties; and life sciences solution to deliver targeted and clinically relevant marketing content to patients, as well as COVID-19 product offerings for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was founded in 2005 and is headquartered in Raleigh, North Carolina.
Latest ACN
- Accenture to Acquire McCoy, Strengthening SAP Expertise and AI Innovation for Mid-Market
- Amendment: Chief Accounting Officer Burgum Melissa A was granted 1,034 units of Class A ordinary shares, increasing direct ownership by 12% to 9,760 units (SEC Form 4)
- CEO-The Americas Walsh John F was granted 24 units of Class A ordinary shares, increasing direct ownership by 0.09% to 26,110 units (SEC Form 4)
- Chief Accounting Officer Burgum Melissa A was granted 23 units of Class A ordinary shares, increasing direct ownership by 0.24% to 9,644 units (SEC Form 4)
- Director Brudermueller Martin was granted 9 units of Class A ordinary shares, increasing direct ownership by 0.54% to 1,690 units (SEC Form 4)
- Director Travis Tracey Thomas was granted 15 units of Class A ordinary shares, increasing direct ownership by 0.15% to 9,829 units (SEC Form 4)
- Director Uotani Masahiko was granted 9 units of Class A ordinary shares, increasing direct ownership by 0.72% to 1,258 units (SEC Form 4)
- Director Nason Jennifer was granted 9 units of Class A ordinary shares, increasing direct ownership by 0.98% to 932 units (SEC Form 4)
- Chair and CEO Sweet Julie Spellman was granted 47 units of Class A ordinary shares, increasing direct ownership by 0.28% to 16,794 units (SEC Form 4)
- Director Mckinstry Nancy was granted 12 units of Class A ordinary shares, increasing direct ownership by 0.15% to 8,107 units (SEC Form 4)
Latest PHR
- President, Network Solutions Linetsky David covered exercise/tax liability with 182 shares (SEC Form 4) (tax liability)
- SEC Form SCHEDULE 13G filed by Phreesia Inc.
- Phreesia Sets Release Date for Fiscal Second Quarter 2027 Results
- Director Munson Gillian was granted 685 shares, increasing direct ownership by 1% to 66,789 units (SEC Form 4)
- Director Goldstein Lainie was granted 377 shares, increasing direct ownership by 0.53% to 70,862 units (SEC Form 4)
- Phreesia and March of Dimes Partner to Help Strengthen Physician-Patient Conversations and Improve the Health of Moms and Babies
- MediFind Launches AI-Powered Chatbot to Help Patients Find and Book the Right Provider
- President, Network Solutions Linetsky David covered exercise/tax liability with 69 shares (SEC Form 4) (tax withholding)
- Principal Accounting Officer Hui Yvonne covered exercise/tax liability with 937 shares and sold $13,617 worth of shares (1,247 units at $10.92) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 21,724 units (SEC Form 4) (tax withholding)
- Director Egbuonu-Davis Lisa sold $5,735 worth of shares (536 units at $10.70) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 37,780 units (SEC Form 4)